Translating molecular pathology into cancer diagnostics [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Precision oncology, the treatment of cancer patients selected with a particular molecular characteristic (biomarker) matched to a therapy, has transformed the treatment of cancer patients. However, many biomarkers used for clinical care are not reliable and do not perform their role. I will translate new research tests from fundamental discovery, clinical trials and the development of novel diagnostics using innovative high throughput laboratory technologies to enhance patient outcomes.

Funding Amount $2,285,520

Funding Scheme Investigator Grants

Chief Investigator Prof Stephen Fox

Notes Leadership 2